Page last updated: 2024-10-31

moclobemide and Brain Edema

moclobemide has been researched along with Brain Edema in 1 studies

Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.

Brain Edema: Increased intracellular or extracellular fluid in brain tissue. Cytotoxic brain edema (swelling due to increased intracellular fluid) is indicative of a disturbance in cell metabolism, and is commonly associated with hypoxic or ischemic injuries (see HYPOXIA, BRAIN). An increase in extracellular fluid may be caused by increased brain capillary permeability (vasogenic edema), an osmotic gradient, local blockages in interstitial fluid pathways, or by obstruction of CSF flow (e.g., obstructive HYDROCEPHALUS). (From Childs Nerv Syst 1992 Sep; 8(6):301-6)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Girard, P1
Verniers, D1
Pansart, Y1
Gillardin, JM1

Other Studies

1 other study available for moclobemide and Brain Edema

ArticleYear
Efficacy of moclobemide in a rat model of neurotoxicant-induced edema.
    Canadian journal of physiology and pharmacology, 2007, Volume: 85, Issue:5

    Topics: Administration, Oral; Animals; Body Mass Index; Brain Edema; Calcium; Cerebral Cortex; Chlorides; Do

2007